Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein
Z. Benderra et al., Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein, EUR J CANC, 36(3), 2000, pp. 428-434
Multidrug resistance (MDR) is frequently associated with the overexpression
of P-glycoprotein (Pgp) and/or multidrug resistance associated protein (MR
P1), both members of the ABC superfamily of transporters. Pgp and MRP1 func
tion as ATP-dependent efflux pumps that extrude cytotoxic drugs from tumour
cells. Glutathione (GSH) has been considered to play an important role in
the MRP1-mediated MDR. In our study, we examined the effects of buthionine
sulphoximine (BSO), an inhibitor of GSH biosynthesis, on the nuclear accumu
lation of daunorubicin (DNR). in etoposide (VP16) and doxorubicin (ADR) res
istant MCF7 cell lines, overexpressing respectively MRP1 (MCF7/VP) and Pgp
(MCF7/ADR). The study of DNR transport was carried out using scanning confo
cal microspectrofluorometry. This technique allows the determination of the
nuclear accumulation of anthracyclines in single living tumour cells. Trea
tment of MCF7/VP cells with BSO increased the sensitivity of these cells to
DNR whilst the cytotoxicity of the drug in MCF7/ADR cells remained unchang
ed. In MCF7 resistant cells treated with BSO, their GSH level decreased as
observed by confocal microscopy. DNR nuclear accumulation in MCF7/VP cells
was increased by BSO whereas in MCF7/ADR cells BSO was unable to significan
tly increase the DNR nuclear accumulation. These data suggest a requirement
for GSH in MRP1-mediated resistance whilst the nuclear efflux of GSH conju
gates is probably not the primary mechanism of Pgp-mediated MDR. Finally, B
SO might be a useful agent in clinical assays for facilitating detection of
MRP1 expression. (C) 2000 Published by Elsevier Science Ltd. All rights re
served.